PharMerica Announces Approval of Merger by Stockholders

14:01 EST 9 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
PharMerica Corporation (NYSE: PMC), announced that at its special meeting of stockholders held today, a majority of the outstanding shares of PharMerica common stock voted to approve the adoption of the previously disclosed defi...

Other Sources for this Article

PharMerica Corporation
Robert E. Dries, 502-627-7475
Executive Vice President and
Chief Financial Officer


More From BioPortfolio on "PharMerica Announces Approval of Merger by Stockholders"

Quick Search


Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.